Bicycle Therapeutics (BCYC) Share-based Compensation (2018 - 2026)

Bicycle Therapeutics' Share-based Compensation history runs 9 years deep, the most recent figure standing at $6.9 million for Q1 2026.

• Quarterly Share-based Compensation fell 27.85% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (down 74.68% YoY) and the FY2025 annual result came in at $16.8 million, down 55.88% from the prior year.
• Share-based Compensation was $6.9 million for Q1 2026 at Bicycle Therapeutics, up from -$15.4 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $10.3 million in Q4 2024 and bottomed at -$15.4 million in Q4 2025.
• A 5-year average of $6.9 million and a median of $8.8 million in 2025 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 166.89% — and 2025, when it sank 249.14%.
• Bicycle Therapeutics' Share-based Compensation stood at $5.5 million in 2022, then soared by 41.01% to $7.8 million in 2023, then soared by 32.27% to $10.3 million in 2024, then sank by 249.14% to -$15.4 million in 2025, then surged by 144.97% to $6.9 million in 2026.
• Business Quant data shows BCYC's Share-based Compensation at $6.9 million in Q1 2026, -$15.4 million in Q4 2025, and $8.8 million in Q3 2025.